FDA Approves First Drug to Treat Severe Multiple Sclerosis – New York Times
New York Times |
FDA Approves First Drug to Treat Severe Multiple Sclerosis
New York Times Jerrie Gullick, 51, was part of the clinical trial for Ocrevus and said the drug had significantly slowed the progression of her primary progressive multiple sclerosis. Credit Sam Hodgson for The New York Times. The Food and Drug Administration … New MS Drug Ocrevus Wins FDA Approval FDA Approves Ocrevus as 1st MS Treatment for Both Relapsing and Primary Progressive Forms Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Biogen |
View original article
Author:
Powered by WPeMatico